{"altmetric_id":3591181,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":2},"wikipedia":{"unique_users_count":2,"unique_users":["en:22625451","en:23058155"],"posts_count":2}},"citation":{"altmetric_jid":"4f6fa5363cf058f610004610","authors":["Danuta Marona-Lewicka","David E. Nichols"],"doi":"10.3109\/10253899709014740","endpage":"99","first_seen_on":"2015-02-13T13:17:51+00:00","issns":["1025-3890","1607-8888"],"issue":"2","journal":"Stress: The International Journal on the Biology of Stress","last_mentioned_on":1260275323,"links":["http:\/\/dx.doi.org\/10.3109\/10253899709014740"],"pubdate":"1997-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"91","subjects":["neurology"],"title":"The Effect of Selective Serotonin Releasing Agents in the Chronic Mild Stress Model of Depression in Rats","type":"article","volume":"2","mendeley_url":"http:\/\/www.mendeley.com\/research\/effect-selective-serotonin-releasing-agents-chronic-mild-stress-model-depression-rats"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3627464,"mean":4.9483847763613,"rank":817652,"this_scored_higher_than_pct":63,"this_scored_higher_than":2286458,"rank_type":"exact","sample_size":3627464,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":94933,"mean":8.1601321366874,"rank":24637,"this_scored_higher_than_pct":72,"this_scored_higher_than":69217,"rank_type":"exact","sample_size":94933,"percentile":72},"this_journal":{"total_number_of_other_articles":133,"mean":2.6160151515152,"rank":25,"this_scored_higher_than_pct":73,"this_scored_higher_than":98,"rank_type":"exact","sample_size":133,"percentile":73},"similar_age_this_journal_3m":{"total_number_of_other_articles":9,"mean":1.34375,"rank":2,"this_scored_higher_than_pct":77,"this_scored_higher_than":7,"rank_type":"exact","sample_size":9,"percentile":77}}},"demographics":{"users":{"mendeley":{"by_status":[],"by_discipline":[]}}},"posts":{"wikipedia":[{"title":"MMAI","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=287003213#altmetric_citation_3","license":"public","citation_ids":[3591181,3591185],"posted_on":"2009-04-30T06:35:28+00:00","summary":"5-Methoxy-6-methyl-2-aminoindane (MMAI), is a drug developed in the 1990s by a team led by David E.","page_url":"http:\/\/en.wikipedia.org\/?curid=22625451","wiki_lang":"en","author":{"name":"Vanished 45kd09la13","url":"http:\/\/en.wikipedia.org\/wiki\/User:Vanished 45kd09la13"}},{"title":"Serotonin releasing agent","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=330446229#altmetric_citation_11","license":"public","citation_ids":[3591181,3591185],"posted_on":"2009-12-08T12:28:43+00:00","summary":"A serotonin releasing agent (SRA) is a type of drug which induces the release of serotonin into the neuronal synaptic cleft, with less significant or no efficacy in producing neurotransmitter efflux at other types of monoamine neurons.","page_url":"http:\/\/en.wikipedia.org\/?curid=23058155","wiki_lang":"en","author":{"name":"Vanished 45kd09la13","url":"http:\/\/en.wikipedia.org\/wiki\/User:Vanished 45kd09la13"}}]}}